2025 SPS Seattle | Caplacizumab in the Immune-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Setting
Overview
NA
Target Audience
Pharmacists
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACCC, FACHE
Date of Release
October 5th, 2025
-1759607393061.webp&w=3840&q=75)
%20to%20Reduce%20Cardiovascular%20Mortality%2C%20Cardiovascular%20Hospitalizations%20and%20Urgent%20Heart%20Failure%20Visits%20(dragged)-1759607143350.webp&w=3840&q=75)